All data are based on the daily closing price as of November 18, 2026
c

Center Laboratories

4123.TWO
0.82 USD
-0.02
-2.38%

Overview

Last close
0.82 usd
Market cap
646.07M usd
52 week high
1.56 usd
52 week low
0.82 usd
Target price
N/A usd

Valuation

P/E
N/A
Forward P/E
2500
Price/Sales
13.1274
Price/Book Value
1.3205
Enterprise Value
731.47M usd
EV/Revenue
13.5431
EV/EBITDA
11.5251

Key financials

Revenue TTM
50.31M usd
Gross Profit TTM
21.77M usd
EBITDA TTM
6.76M usd
Earnings per Share
-0.08 usd
Dividend
N/A usd
Total assets
702.94M usd
Net debt
99.05M usd

About

Center Laboratories, Inc., a pharmaceutical company, develops, manufactures, and sells pharmaceuticals in Taiwan and internationally. The company offers general medication pharmaceuticals comprising antipyretic analgesics, bronchodilators, anti-inflammatory preparations, antihistamines, expectorants, narcotic antitussives and expectorants, gastrointestinal preparations, non-narcotic antitussives and expectorants, and other medicines. It also provides central nervous system medication consisting of treatments for cerebrovascular disease, dementia, depression, schizophrenia, epilepsy, and Parkinson's disease. Center Laboratories, Inc. was founded in 1959 and is headquartered in Taipei, Taiwan.
  • Symbol
    4123.TWO
  • Exchange
    TWO
  • Isin
    TW0004123005
  • Country
    Taiwan
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
    Ms. Su-Chi Wang
  • Headquarter
    Taipei
  • Web site
    https://www.centerlab.com.tw
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top